HighGravityData
Companies / Healthcare payers & distributors / LH

Labcorp

LH · Healthcare payers & distributors sector group
Guidance from Labcorp’s last 8 earnings releases. Every value links to its sentence in the filing. See something wrong? Tell us.
Current guidance
10 items
Releases tracked
8
Latest release
Jul 30, 2026
Data checked
Jul 30, 2026
On this page:Latest changes·Current guidance·Your sector group·History

What changed in the Jul 30, 2026 release

Each item compared with the same item in the previous release (Apr 30, 2026). Values in quotation marks are the company’s words.

New — first stated in this releaseRaised / Lowered / Narrowed / Widened — changed from the prior releaseRevised — wording changed, direction not determinableChanged — value changed; the comparison couldn’t be parsed to a directionReiterated — restated unchangedNot restated — stated before, absent nowRaised and lowered describe the number, not whether the change is favorable.
ChangeMetricPeriodPreviousNowSource
NewAdjusted EPS rangefor FY2026—“$18.10 to $18.55”Filing ↗
RaisedNext Twelve Months Forecast Backlog ConversionNo period stated“$2.66”“$2.75”Filing ↗
Show 7 items not restated in this release
ChangeMetricPeriodPreviousNowSource
Not restatedBiopharma Laboratory Services Revenuefor FY2026“$3.22 $3.27”—Filing ↗
Not restatedDiagnostics Laboratories Revenuefor FY2026“$11.43 $11.52”—Filing ↗
Not restatedLabcorp Enterprise Revenuefor FY2026“$14.65 $14.80”—Filing ↗
Not restatedRevenuefor FY2026“$14.61 billion to $14.79 billion”—Filing ↗
Not restatedRevenue - Labcorp Enterprise (dollar)for FY2026“$14.61 billion to $14.79 billion”—Filing ↗
Not restatedAdjusted EPS midpointfor FY2026“$18.03”—Filing ↗
Not restatedFree Cash Flowfor FY2026“$1.24 $1.36”—Filing ↗

Current guidance

Guidance for periods that have not yet ended, at its most recent value, grouped by horizon.

Current fiscal year
MetricCurrent valuePeriodMeasureFirst statedTimes statedSource
Biopharma Laboratory Services Revenue“$3.22 $3.27”for FY2026GAAP-tiedApr 30, 20261Filing ↗
Diagnostics Laboratories Revenue“$11.43 $11.52”for FY2026GAAP-tiedApr 30, 20261Filing ↗
Enterprise Revenue“5.0% to 6.1%”for FY2026GAAP-tiedApr 30, 20261Filing ↗
Labcorp Enterprise Revenue“$14.65 $14.80”for FY2026GAAP-tiedApr 30, 20261Filing ↗
Revenue“$14.61 billion to $14.79 billion”for FY2026GAAP-tiedFeb 17, 20261Filing ↗
Revenue - Labcorp Enterprise (dollar)“$14.61 billion to $14.79 billion”for FY2026GAAP-tiedFeb 17, 20261Filing ↗
Adjusted EPS“$17.70 to $18.35”for FY2026Company-definedFeb 17, 20262Filing ↗
Adjusted EPS midpoint“$18.03”for FY2026Company-definedApr 30, 20261Filing ↗
Adjusted EPS range“$18.10 to $18.55”for FY2026Company-definedJul 30, 20261Filing ↗
Free Cash Flow“$1.24 $1.36”for FY2026Company-definedFeb 17, 20262Filing ↗
Quarterly cash dividend“$0.72 per share”for FY2026Declared actionFeb 17, 20262Filing ↗
Quarterly cash dividend per share“$0.72”for FY2026Declared actionJul 30, 20261Filing ↗
No period stated
MetricCurrent valuePeriodMeasureFirst statedTimes statedSource
Quarterly cash dividend“$0.72 per share”—Declared actionOct 24, 20247Filing ↗
Share repurchase authorization increase“$1.0 billion”—Declared actionJul 30, 20261Filing ↗
Share repurchase authorization, remaining total“$1.4 billion”—Declared actionJul 30, 20261Filing ↗

How one item moved

Next Twelve Months Forecast Backlog Conversion, No period stated — every statement across the year, each linked to its filing.

Apr 29, 2025
New
“$2.56”
Filing ↗
Oct 28, 2025
Raised
“$2.66”
Filing ↗
Jul 30, 2026
Raised
“$2.75”
Filing ↗

How your Healthcare payers & distributors sector group guides

12 companies in Healthcare payers & distributors. What they guide on, and who reported this season.

Most-guided metric families
Revenue
11
Adjusted EPS
11
GAAP EPS
10
Tax rate
9
Share count
8
Dividends
8
Buybacks
8
Capex
6
This season’s releases
UnitedHealth GroupOct 13, 20265 changes
Cardinal HealthAug 11, 202613 changes
CencoraAug 5, 202611 changes
CVS HealthAug 5, 20265 changes
McKessonAug 5, 20261 change
LabcorpJul 30, 20262 changes
The Cigna GroupJul 30, 20263 changes
HumanaJul 29, 20264 changes
Get this for your own peer set — Peer Guidance Briefing, $3,000.

Full history

Every metric, every release, eight quarters — the complete record as one table.

MetricFY2026FY2025FY2024No period
Biopharma Laboratory Services Revenue1 statement———
Diagnostics Laboratories Revenue1 statement———
Enterprise Revenue1 statement———
Labcorp Enterprise Revenue2 statements1 statement1 statement—
Revenue1 statement1 statement——
The full record for Labcorp and its Healthcare payers & distributors peers, delivered as a Peer Guidance Briefing — PDF and Excel, every value linked to its filing.

Filings

The 8 earnings releases this page is built from.

FiledFiscal periodAccessionGuidance items
Jul 30, 2026FY2026 Q20000920148-26-0001626Open filing ↗
Apr 30, 2026FY2026 Q10000920148-26-0001358Open filing ↗
Feb 17, 2026FY2025 Q40000920148-26-0000986Open filing ↗
Oct 28, 2025FY2025 Q30000920148-25-0000935Open filing ↗
Jul 24, 2025FY2025 Q20000920148-25-0000754Open filing ↗
Apr 29, 2025FY2025 Q10000920148-25-0000545Open filing ↗
Feb 6, 2025FY2024 Q40000920148-25-0000216Open filing ↗
Oct 24, 2024FY2024 Q30000920148-24-0001155Open filing ↗
Values in quotation marks are the company’s words; the classification and filing links are HighGravityData’s. HighGravityData does not score or rank companies or give investment advice.
Report an error